279 related articles for article (PubMed ID: 24365796)
1. Effects of rebamipide on nephrotoxicity associated with selected NSAIDs in rats.
Wood RC; Wyatt JE; Bullins KW; Hanley AV; Hanley GA; Denham JW; Panus PC; Harirforoosh S
Eur J Pharmacol; 2013 Nov; 720(1-3):138-46. PubMed ID: 24365796
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic interactions between rebamipide and selected nonsteroidal anti-inflammatory drugs in rats.
Cooper DL; Wood RC; Wyatt JE; Harirforoosh S
Eur J Pharm Sci; 2014 Mar; 53():28-34. PubMed ID: 24342124
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of rebamipide against celecoxib-induced gastric mucosal cell apoptosis.
Ishihara T; Tanaka K; Tashiro S; Yoshida K; Mizushima T
Biochem Pharmacol; 2010 Jun; 79(11):1622-33. PubMed ID: 20132796
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib or diclofenac hepatic status in the presence or absence of rebamipide.
Murrell DE; Rahmasari Y; Denham JW; Panus PC; Harirforoosh S
Eur Rev Med Pharmacol Sci; 2015 Sep; 19(17):3318-25. PubMed ID: 26400540
[TBL] [Abstract][Full Text] [Related]
5. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent.
Sun WH; Tsuji S; Tsujii M; Gunawan ES; Kawai N; Kimura A; Kakiuchi Y; Yasumaru M; Iijima H; Okuda Y; Sasaki Y; Hori M; Kawano S
J Pharmacol Exp Ther; 2000 Nov; 295(2):447-52. PubMed ID: 11046075
[TBL] [Abstract][Full Text] [Related]
6. Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy.
Fujimori S; Takahashi Y; Gudis K; Seo T; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
J Gastroenterol; 2011 Jan; 46(1):57-64. PubMed ID: 20924615
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.
Chan FK; Lanas A; Scheiman J; Berger MF; Nguyen H; Goldstein JL
Lancet; 2010 Jul; 376(9736):173-9. PubMed ID: 20638563
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis.
Chan FK; Hung LC; Suen BY; Wu JC; Lee KC; Leung VK; Hui AJ; To KF; Leung WK; Wong VW; Chung SC; Sung JJ
N Engl J Med; 2002 Dec; 347(26):2104-10. PubMed ID: 12501222
[TBL] [Abstract][Full Text] [Related]
9. Rebamipide attenuates nonsteroidal anti-inflammatory drugs (NSAID) induced lipid peroxidation by the manganese superoxide dismutase (MnSOD) overexpression in gastrointestinal epithelial cells.
Nagano Y; Matsui H; Shimokawa O; Hirayama A; Tamura M; Nakamura Y; Kaneko T; Rai K; Indo HP; Majima HJ; Hyodo I
J Physiol Pharmacol; 2012 Apr; 63(2):137-42. PubMed ID: 22653900
[TBL] [Abstract][Full Text] [Related]
10. Exacerbation of celecoxib-induced renal injury by concomitant administration of misoprostol in rats.
Cooper DL; Murrell DE; Conder CM; Palau VE; Campbell GE; Lynch SP; Denham JW; Hanley AV; Bullins KW; Panus PC; Singh K; Harirforoosh S
PLoS One; 2014; 9(2):e89087. PubMed ID: 24586517
[TBL] [Abstract][Full Text] [Related]
11. Protective effect and mechanism of rebamipide on NSAIDs associated small bowel injury.
Xu N; Zhang C; Jing L; Mou S; Cao X; Yu Z
Int Immunopharmacol; 2021 Jan; 90():107136. PubMed ID: 33218942
[TBL] [Abstract][Full Text] [Related]
12. Extent of renal effect of cyclo-oxygenase-2-selective inhibitors is pharmacokinetic dependent.
Harirforoosh S; Aghazadeh-Habashi A; Jamali F
Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):917-24. PubMed ID: 17002668
[TBL] [Abstract][Full Text] [Related]
13. Effect of nonsteroidal anti-inflammatory drugs with varying extent of COX-2-COX-1 selectivity on urinary sodium and potassium excretion in the rat.
Harirforoosh S; Jamali F
Can J Physiol Pharmacol; 2005 Jan; 83(1):85-90. PubMed ID: 15759054
[TBL] [Abstract][Full Text] [Related]
14. Comparison of antinociceptive efficacy and gastroprotection between celecoxib and diclofenac plus misoprostol in rats.
Reyes-García G; Déciga-Campos M; Medina-Santillan R; Granados-Soto V
Proc West Pharmacol Soc; 2007; 50():69-71. PubMed ID: 18605234
[TBL] [Abstract][Full Text] [Related]
15. Preventive efficacy and safety of rebamipide in nonsteroidal anti-inflammatory drug-induced mucosal toxicity.
Kim JH; Park SH; Cho CS; Lee ST; Yoo WH; Kim SK; Kang YM; Rew JS; Park YW; Lee SK; Lee YC; Park W; Lee DH
Gut Liver; 2014 Jul; 8(4):371-9. PubMed ID: 25071901
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.
Niwa Y; Nakamura M; Ohmiya N; Maeda O; Ando T; Itoh A; Hirooka Y; Goto H
J Gastroenterol; 2008; 43(4):270-6. PubMed ID: 18458842
[TBL] [Abstract][Full Text] [Related]
17. The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials.
Soni P; Shell B; Cawkwell G; Li C; Ma H
Curr Med Res Opin; 2009 Aug; 25(8):1841-51. PubMed ID: 19530981
[TBL] [Abstract][Full Text] [Related]
18. The effect of rebamipide on cisplatin-induced nephrotoxicity in rats.
Saad SY; Najjar TA; Al-Sohaibani MO
Pharmacol Res; 2000 Jul; 42(1):81-6. PubMed ID: 10860639
[TBL] [Abstract][Full Text] [Related]
19. Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.
Satoh H; Amagase K; Takeuchi K
J Pharmacol Exp Ther; 2014 Feb; 348(2):227-35. PubMed ID: 24254524
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
Singh G; Fort JG; Goldstein JL; Levy RA; Hanrahan PS; Bello AE; Andrade-Ortega L; Wallemark C; Agrawal NM; Eisen GM; Stenson WF; Triadafilopoulos G;
Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
